Watch About Donate Blog

Steve Davidsen

Vice President, Oncology Discovery, AbbVie Biopharmaceuticals
Steve Davidsen, Ph.D., is Vice President, Oncology Discovery in AbbVie’s R&D organization, where he is responsible for discovery and research efforts of AbbVie’s Oncology programs. He has been a critical leader in building AbbVie’s Oncology pipeline, directing research teams and partnerships that have led to more than 55 current Oncology trials in more than 15 different cancer and tumor types. He steered the expansion of AbbVie’s efforts in oncology biologics and translational biology and has more than 70 scientific publications across a diverse range of topics including metalloproteinase inhibitors, kinase inhibitors and the discovery of PAF antagonists.
VIDEOS...